For the third consecutive week, stocks in the medtech industry reached heights not yet seen since the COVID-19 pandemic began. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.65 points at the end of last week (Aug. 7). Overall, medtech stocks saw a 0.72% increase from […]
Initial Public Offering (IPO)
Acutus Medical launches IPO on Nasdaq
Cardiac mapping technology developer Acutus Medical announced that it priced its initial public offering on the Nasdaq market. The Carlsbad, Calif.-based company is offering 8,823,529 shares of its common stock at $18 per share, with gross proceeds expected to come in at approximately $158.8 million. Acutus Medical’s shares are expected to begin trading today (Aug.6, […]
Perimeter Medical Imaging to go public in Toronto
Perimeter Medical Imaging — creator of AI-based medical imaging tools for cancer surgery — plans to go public on the TSX Venture Exchange in Toronto on the week of June 29. The Toronto- and Dallas-based company is going public at the same time that it enters the commercial stage for its proprietary, FDA-cleared OCT imaging […]
Inari Medical to raise $156m in upsized IPO
Inari Medical (NSDQ:NARI) announced that it upsized its initial public offering of common stock shares for total gross proceeds of approximately $156 million. Earlier this week, the venous disease treatment developer announced that it launched the roadshow for its initial public offering (IPO) of shares of its common stock, planning to offer more than 7.3 million […]
Inari Medical plans to launch IPO to raise more than $110m
Inari Medical announced today that it launched the roadshow for its initial public offering (IPO) of shares of its common stock. The venous disease treatment developer is offering more than 7.3 million shares of common stock with an expected additional 30-day option for underwriters to purchase close to 1.1 million more shares. Irvine, Calif.-based Inari […]
Medtech startups rack up strong VC totals in Q1, but future uncertain, SVB says
Medtech startups raising venture capital in the first quarter kept the strong pace from 2019, according to an analysis by Silicon Valley Bank. But the uncertainty over the pandemic likely will slow down fund-raising in the second quarter. In an interview with DeviceTalks Weekly Podcast, Jonathan Norris, managing director, SVB Life Sciences, says SVB recorded […]
Rani Therapeutics could go the IPO route
Rani Therapeutics is reportedly moving forward with an early-stage efficacy and safety study for its robotic pills and may be on its way toward the possibility of an IPO. According to a report in Endpoints News, Rani, led by CEO Mir Imran who shared the story on LinkedIn, revealed that its RaniPill performed as expected with 58 […]
Shockwave Medical prices $75 million offering
Shockwave Medical (NSDQ:SWAV) filed a common stock equity offering with the SEC priced at $75 million. The Santa Clara, Calif.–based company said in yesterday’s filing that at the assumed public offering price of $36.14 that was reported on Nov. 11, it expects to offer nearly 2.1 million shares of common stock. Shockwave said it anticipates approximately […]
Frequency Therapeutics prices $84m IPO
Frequency Therapeutics said yesterday that it priced its initial public offering at roughly $84 million. The 6-million-share offering priced at $14 per share and includes a 30-day underwriters option on another 900,000 shares that’s worth $12.6 million, the Woburn, Mass.-based company said. Get the full story at our sister site, Drug Delivery Business News.
Danaher dental spinout Envista closes $677m IPO
Envista (NYSE:NVST), the dental business spinout from Danaher (NYSE:DHR), last week closed its initial public offering at $677 million, including more than $88 million from the underwriters. Brea, Calif.-based Envista floated nearly 26.8 million shares at $22.00 apiece, grossing $588.9 million, plus more than 4.0 million shares in fully subscribed underwriters option. Net proceeds of about $643.4 million […]
Danaher dental spinout Envista prices $589m IPO
Envista (NYSE:NVST), the dental business spinout from Danaher (NYSE:DHR), yesterday priced its initial public offering at $589 million, sending its overall valuation well above the $3 billion mark. The spinout, announced in July 2018, will unite the Nobel Biocare, KaVo Kerr and Ormco dental brands under the Envista umbrella. The nearly 26.8-million-share flotation, at $22 per share, is for […]
